CC(C)(C)S(=O)(=O)N1Cc2cc(=O)n(Cc3ccccc3)c(CCO)c2[C@@H]1CCO
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?